MicroRNAs as Biomarkers in Thyroid Carcinoma

Table 4

Tissue miRNAs as prognostic biomarkers in PTC.

miRNA	Tumor size	Multifocality	Capsular invasion	Vascular invasion	ETE	LN metastases	Distant metastases	Overall survival	TNM stage	ATA risk	References
1179											Rosignolo et al. [37]
125b											Geraldo and Kimura [92]
135b											Wang et al. [35]
138											Geraldo and Kimura [92]
146a											Sun et al. [87]
146b											Wang et al. [35], Acibucu et al. [86], Sun et al. [87], Chou et al. [91], Geraldo and Kimura [92]
146b-3p											Rosignolo et al. [37]
146b-5p											Rosignolo et al. [37]
181b											Sun et al. [85]
199a-3p/199b-3p											Rosignolo et al. [37]
											Rosignolo et al. [37]
199b-5p											Peng et al. [89]
203											Geraldo and Kimura [92]
204-5p											Rosignolo et al. [37]
21											Geraldo and Kimura [92]
21-3p											Huang et al. [90]
21-5p											Rosignolo et al. [37]
221											Wang et al. [35], Sun et al. [85], Acibucu et al. [86], Wang et al. [88], Geraldo and Kimura [92]
222											Wang et al. [35], Sun et al. [85], Acibucu et al. [86], Wang et al. [88], Geraldo and Kimura [92]
222-3p											Rosignolo et al. [37]
30a											Geraldo and Kimura [92]
31-5p											Rosignolo et al. [37]
7–2-3p											Rosignolo et al. [37]
let-7c											Geraldo and Kimura [92]

: information included in indicated studies; ATA: American Thyroid Association; ETE: extrathyroidal extension; LN: lymph node.